Thirona LungQ
by Thirona
LungQ is Thirona's AI-powered quantitative CT analysis platform for pulmonary disease. It uses AI-driven segmentation and quantification to detect, measure, and track lung disease (COPD, cystic fibrosis, bronchiectasis, severe asthma) from thoracic CT scans, supporting pharmaceutical clinical trials (treatment efficacy assessment) and pulmonary interventions (AI-enabled bronchoscopic/surgical imaging). LungQ4 and LungQ v3.y.z hold current FDA 510(k) clearance and EU MDR CE marking (Class II/IIb) as regulated medical devices.
Transparency Score
Weighted across four pillars · updated September 14, 2026
Capabilities
Vendor Information
Complete information about the vendor/provider of this AI application
EU AI Act Provider Information
Get insights into risk by running assessments on this AI application.
Work at Thirona? Claim this listing to correct or complete the data.
Ready to manage AI applications?
Track, assess, and govern your AI applications with Anove.